Whoop Just Tripled Its Valuation to $10 Billion — And the Wearable Tech Race Is Heating Up
Whoop, the Boston-based fitness and health wearable company, has just closed a massive $575 million Series G funding round at a staggering $10.1 billion valuation. That figure is nearly triple its last known valuation of $3.6 billion, making it one of the most dramatic valuation leaps in wearable tech history. If you've been following the health tracking industry, this is a moment you won't want to sleep on.
 |
| Credit: Whoop |
From Niche Fitness Tool to Billion-Dollar Health Platform
Not long ago, Whoop was considered a product for elite athletes — the kind of bracelet you'd spot on a professional basketball player or an Olympic sprinter. Today, that narrative has shifted completely. Whoop has grown into a mainstream health platform used by millions of performance-conscious consumers around the world. The company's latest funding round includes some of the world's most powerful institutional investors, sovereign wealth funds, and some of the biggest names in sport and entertainment.
The round was led by Collaborative Fund and includes participation from Mubadala Investment Company, Qatar Investment Authority, Abbott, Mayo Clinic, Macquarie Capital, IVP, and several other major players. Individual investors include Cristiano Ronaldo, LeBron James, Rory McIlroy, Reggie Miller, and Niall Horan. When athletes of that caliber are writing checks into a company they already wear on their wrists, it sends a clear signal to the broader market about where health wearables are heading.
Why a $10 Billion Valuation Makes Sense Right Now
Some might raise an eyebrow at a $10 billion price tag for a wearable hardware company, but the underlying numbers tell a compelling story. Whoop exited 2025 at a $1.1 billion bookings run rate, up 103 percent year over year. That kind of growth is not something you see from a company coasting on brand recognition alone. It reflects genuine consumer demand, a sticky subscription model, and an expanding product ecosystem that increasingly overlaps with healthcare.
Whoop founder and CEO Will Ahmed has been intentional about why bookings is the metric that matters most for a company like his. When you're simultaneously shipping millions of hardware units globally and running a recurring subscription business, the financial picture is layered. There's inventory, hardware costs, and monthly recurring revenue all happening at once. Bookings captures that complexity better than any single-line metric, and for investors, that transparency is reassuring.
The company has now raised roughly $900 million in total since its founding — a serious war chest for a brand that is still, by most measures, in high-growth mode.
The Abbott Partnership Changes the Conversation
One of the most closely watched elements of this funding round is the inclusion of Abbott, the global medical device giant, as an investor. Abbott's products span diagnostics, heart rhythm devices, continuous glucose monitors, and more. Their presence on Whoop's cap table is not a casual check. It signals a deliberate strategic move toward health and medical capabilities.
Ahmed acknowledged the partnership directly, noting that "more is to come" on what the Abbott relationship will specifically unlock. For health-conscious consumers, that hint is worth paying attention to. The gap between fitness tracking and clinical health monitoring has been narrowing for years. Whoop's alignment with Abbott suggests the company is preparing to close that gap faster than most people expect. The addition of Mayo Clinic as an investor only reinforces that direction.
International Expansion and Talent Are Next on the Agenda
So what does a company do with $575 million in fresh capital? According to Ahmed, the priorities are clear: attracting top talent, boosting marketing and brand awareness, accelerating research and development, and pushing hard on international expansion. Whoop has significant headroom to grow outside the United States, particularly in markets where health-conscious middle classes are expanding rapidly and wearable technology adoption is accelerating.
The talent piece is especially interesting. Ahmed mentioned ambitious hiring plans, suggesting Whoop is building toward a larger, more complex organization than it has been historically. For a company that has operated with a tight, focused team for most of its existence, scaling headcount strategically while maintaining product quality will be one of its defining challenges in the years ahead.
Is an IPO on the Horizon?
The question every investor and industry observer is asking right now is whether Whoop is preparing to go public. Ahmed was measured but transparent in his response. He said the company is doing what he called "a lot of the no-regrets work to be a public company" — the kinds of internal infrastructure, financial reporting, and governance upgrades that any company would want in place before ringing a stock exchange bell. However, he stopped well short of hinting at an imminent IPO timeline.
The broader context makes this question even more pointed. Whoop's closest competitor in the subscription-based wearable space is reportedly in conversations with investment banks about a public offering this year. If that move happens and generates strong market reception, it could accelerate the timeline for Whoop as well. For now, the company has enough runway to be patient. Patience, combined with a $10 billion price tag and growing retail brand recognition, could make a future Whoop IPO one of the more anticipated tech listings of the decade.
Whoop and the AI Integration Opportunity
Beyond hardware and subscriptions, Whoop is also actively incorporating artificial intelligence into its core product experience. The company has not published detailed specifics about its AI roadmap, but Ahmed has spoken openly about AI's role in the company's future. The health wearable space is arguably one of the richest environments for AI application — continuous biometric data streams, personalized recovery insights, sleep optimization, and predictive health modeling all benefit enormously from machine learning.
As AI tools become more sophisticated and more embedded in everyday health apps, the companies that have already built large proprietary datasets and strong user engagement will have a serious head start. Whoop, with millions of active subscribers generating round-the-clock biometric data, is well-positioned to leverage that advantage. The combination of AI, medical-grade partnerships, and a loyal consumer base creates a moat that is increasingly hard for newer entrants to replicate.
What This Means for the Wearable Tech Industry
Whoop's rise to a $10 billion valuation is not happening in isolation. It reflects a broader shift in how consumers, investors, and healthcare institutions are thinking about personal health data. Wearables are no longer novelty gadgets. They are becoming foundational tools in preventive health, chronic disease management, and performance optimization. The inclusion of sovereign wealth funds from the Gulf region alongside institutions like Mayo Clinic signals that global capital is taking this trend seriously.
For everyday consumers, the competition between wearable platforms means better products, more features, and increasingly meaningful health insights delivered through devices worn daily. For investors, Whoop's trajectory offers a case study in how a hardware brand can escape the commoditization trap by layering in software, subscriptions, and now healthcare — building toward something that looks less like a gadget company and more like a health intelligence platform.
The Bottom Line on Whoop's $10 Billion Moment
Whoop entering the $10 billion club is more than a funding headline. It is a marker of how far health wearables have come and how much further they are likely to go. With elite athlete endorsers, sovereign wealth fund backing, a medical device giant as a strategic partner, and a CEO who is clearly building toward something larger than fitness tracking, Whoop has positioned itself at the center of one of the most consequential intersections in modern technology — the place where consumer hardware meets personal health at scale.
Whether an IPO comes in 2026 or 2027, whether the Abbott partnership unlocks new clinical features, or whether international expansion opens entirely new revenue channels, one thing is already clear: Whoop is no longer just a fitness band. It is becoming a platform, and a $10 billion valuation is just the beginning of that story.
